These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30639231)

  • 21. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.
    Gawrieh S; Noureddin M; Loo N; Mohseni R; Awasty V; Cusi K; Kowdley KV; Lai M; Schiff E; Parmar D; Patel P; Chalasani N
    Hepatology; 2021 Oct; 74(4):1809-1824. PubMed ID: 33811367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial.
    Darand M; Darabi Z; Yari Z; Saadati S; Hedayati M; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Complement Ther Med; 2019 Jun; 44():204-209. PubMed ID: 31126557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial.
    Darand M; Darabi Z; Yari Z; Hedayati M; Shahrbaf MA; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Phytother Res; 2019 Sep; 33(9):2369-2377. PubMed ID: 31293021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
    Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial.
    Atefi M; Entezari MH; Vahedi H; Hassanzadeh A
    Int J Clin Pract; 2022; 2022():4982080. PubMed ID: 35685535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of
    Rashidmayvan M; Mohammadshahi M; Seyedian SS; Haghighizadeh MH
    J Diabetes Metab Disord; 2019 Dec; 18(2):453-459. PubMed ID: 31890671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.
    Panahi Y; Kianpour P; Mohtashami R; Atkin SL; Butler AE; Jafari R; Badeli R; Sahebkar A
    Phytother Res; 2018 Jul; 32(7):1382-1387. PubMed ID: 29520889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
    Zhu FS; Liu S; Chen XM; Huang ZG; Zhang DW
    World J Gastroenterol; 2008 Nov; 14(41):6395-400. PubMed ID: 19009658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of Nigella sativa seeds against carbon tetrachloride-induced liver damage.
    Al-Ghamdi MS
    Am J Chin Med; 2003; 31(5):721-8. PubMed ID: 14696675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nigella sativa on various parameters in Patients of non-alcoholic fatty liver disease.
    Hussain M; Tunio AG; Akhtar L; Shaikh GS
    J Ayub Med Coll Abbottabad; 2017; 29(3):403-407. PubMed ID: 29076670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
    Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials.
    Zhou J; Chen Y; Yu J; Li T; Lu Z; Chen Y; Zhang X; Ye F
    Medicine (Baltimore); 2021 Mar; 100(12):e24884. PubMed ID: 33761646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
    Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):613-617. PubMed ID: 30920975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
    Rahmani S; Asgary S; Askari G; Keshvari M; Hatamipour M; Feizi A; Sahebkar A
    Phytother Res; 2016 Sep; 30(9):1540-8. PubMed ID: 27270872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.